Orgenesis Inc.
ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio—
52W High$5.89
52W Low$0.02
Orgenesis Inc. (ORGS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ORGS · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 26, 2026EPS Actual
-$4.38
Est. -$2.60 · -68.5%
Revenue
—
Est. $0.00B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 26, 2026
After Market Close
▼ Miss EPS
ORGS reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 7, 2026 | -$2.30 | — | — | — | $0.00B | — |
| ◌ Q1 FY2026 | Mar 26, 2026 | $2.50 | — | — | — | $0.02B | — |
| ▼ Q1 FY2026 | Mar 26, 2026 | -$2.60 | -$4.38 | -68.5% | — | $0.00B | — |
| ◌ Q4 FY2025 | Nov 11, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 11, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 15, 2025 | — | — | — | — | — | — |
| ▼ Q4 FY2024 | Nov 13, 2024 | $1.70 | -$1.93 | -213.5% | $0.00B | $0.02B | -98.1% |
| ▼ Q3 FY2024 | Aug 8, 2024 | $1.40 | -$2.30 | -264.3% | $0.00B | $0.00B | +49.1% |
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
-$2.30
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 26, 2026
EPS Actual
—
EPS Est.
$2.50
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 26, 2026Miss
EPS Actual
-$4.38
EPS Est.
-$2.60
EPS Surpr.
-68.5%
Revenue
—
Q4 FY2025
Nov 11, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 11, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 15, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$1.93
EPS Est.
$1.70
EPS Surpr.
-213.5%
Revenue
$0.00B
Q3 FY2024
Aug 8, 2024Miss
EPS Actual
-$2.30
EPS Est.
$1.40
EPS Surpr.
-264.3%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2030 | $2.50 | $2.50 | $2.50 | 1 |
| Q2 FY2030 | $1.70 | $1.70 | $1.70 | 1 |
| Q1 FY2030 | $1.40 | $1.40 | $1.40 | 1 |
| Q4 FY2029 | $2.50 | $2.50 | $2.50 | 1 |
| Q3 FY2029 | $1.70 | $1.70 | $1.70 | 1 |
| Q2 FY2029 | $1.40 | $1.40 | $1.40 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Mar 26, 2026 | -68.5% | $0.21 | $0.50 | +138.10% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -213.5% | $1.20 | $1.25 | +4.17% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -264.3% | $7.10 | $7.90 | +11.27% |
| ▼ Q2 FY2024 | May 21, 2024 | -825.0% | $5.50 | $5.10 | -7.27% |
| ▼ Q2 FY2024 | Apr 15, 2024 | -744.4% | $4.90 | $5.00 | +2.04% |
| ▼ Q2 FY2024 | Apr 15, 2024 | -107.1% | $4.90 | $5.00 | +2.04% |
| — Q2 FY2024 | Apr 15, 2024 | — | $4.90 | $5.00 | +2.04% |
Q1 FY2026+138.10%
Report Date
Mar 26, 2026
EPS Beat/Miss
-68.5%
Price Before
$0.21
Price After
$0.50
Q4 FY2024+4.17%
Report Date
Nov 13, 2024
EPS Beat/Miss
-213.5%
Price Before
$1.20
Price After
$1.25
Q3 FY2024+11.27%
Report Date
Aug 8, 2024
EPS Beat/Miss
-264.3%
Price Before
$7.10
Price After
$7.90
Q2 FY2024-7.27%
Report Date
May 21, 2024
EPS Beat/Miss
-825.0%
Price Before
$5.50
Price After
$5.10
Q2 FY2024+2.04%
Report Date
Apr 15, 2024
EPS Beat/Miss
-744.4%
Price Before
$4.90
Price After
$5.00
Q2 FY2024+2.04%
Report Date
Apr 15, 2024
EPS Beat/Miss
-107.1%
Price Before
$4.90
Price After
$5.00
Q2 FY2024+2.04%
Report Date
Apr 15, 2024
EPS Beat/Miss
—
Price Before
$4.90
Price After
$5.00
Avg Miss Reaction+25.06%
Beat Rate0 / 7 quarters
Largest Move+138.10% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ORGS ends December
Orgenesis Inc. (ORGS) most recently reported earnings on March 26, 2026 for Q1 FY2026, posting EPS of $-4.38 — missing the analyst consensus of $-2.60 by -68.5%. The next ORGS earnings date is expected around September 1, 2026.
Each quarter, investors track ORGS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ORGS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ORGS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ORGS earnings · 5 questionsOrgenesis Inc.'s next earnings report is expected around September 1, 2026. ORGS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ORGS historically reports after market close (AMC).
ORGS earnings datewhen is ORGS earningsORGS next earnings datewhen does ORGS report earningsORGS earnings calendar
▸ Source: FMP · Orgenesis Inc. SEC filings · US GAAP · Orgenesis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026